IL2 and diabetes mellitus: ELISA assays showed that the injection of tRF‐1020 mimics alleviated diabetes‐induced retinal inflammation as shown by decreased expression of VEGF, interleukin (IL)‐2, and TNF‐α (Figure 3F–H).